SEC Form 4 · accession 0001493152-15-000857
OncBioMune Pharmaceuticals, Inc · OBMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Constantin Dietrich
Officer — Chief Executive Officer · Director
Period of report
Mar 10, 2015
Accepted (ET)
Mar 18, 2015 · 1:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001362703
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 10, 2015 | S | 6,375,000 | $0.0001 | D | 6,375,000 | D | |
| Common StockF1 | Mar 10, 2015 | S | 6,375,000 | $0.0001 | D | 0 | D | |
| Common StockF1,F2,F3 | Mar 10, 2015 | S | 300,000 | $0.0001 | D | 0 | I | by 3cl Holding GmbH |
| Common StockF1,F2 | Mar 10, 2015 | P | 300,000 | $0.0001 | A | 300,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Amount gives effect to a 3-for-1 stock split that was effective as of August 7, 2013.
- F2On March 10, 2015, 3cl Holding GmbH, which is deemed to be beneficially owned by Mr. Dietrich, sold 300,000 shares of the issuer's common stock to Mr. Dietrich. As a result of the transaction, the shares previously held indirectly by Mr. Dietrich through his ownership of 3cl Holding GmbH (see footnote (2) below) are now held directly by Mr. Dietrich.
- F33cl Holding GmbH is a limited liability company, based in Germany and 100% owned by Mr. Dietrich's family. Mr. Dietrich and his wife together own about 70% of this company, while Mr. Dietrich's in-laws own the rest. One of Mr. Dietrich's in-laws is the only managing director of this company.